Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any Meier-Gorlin syndrome in which the cause of the disease is a mutation in the ORC4 gene.
Features include always present findings: Short stature, Narrow mouth, Microtia, and Delayed skeletal maturation and others; and common findings: Microcephaly and Patellar aplasia. 26 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Growth and development | 3 | Short stature, Failure to thrive, Intrauterine growth retardation |
ORC4 encodes origin recognition complex subunit 4 (436 aa). Component of the origin recognition complex (ORC) that binds origins of replication. DNA-binding is ATP-dependent. Highest expression in Brain Cerebellar Hemisphere (21.4 TPM) and Brain Cerebellum (18.3 TPM).
Meier-Gorlin syndrome 2 has been associated with mutations in the ORC4 gene on chromosome 2.
ORC4 is classified as a druggable target with score 0.0.
Genetic testing for ORC4 is available. Testing is considered supportive for diagnosis.
Biomarker and diagnostic research for Meier-Gorlin syndrome 2 has been reported in the published literature.
Phenotype severity distribution: 9 always present features, 2 common features.
No clinical trials have been registered for Meier-Gorlin syndrome 2.
6 publications have been identified in PubMed for Meier-Gorlin syndrome 2. Research spans Basic Science / Preclinical (50%), Diagnostic / Biomarker (17%), and Review / Meta-Analysis (17%).
Yang R (2026). [PMID: 41448435](https://pubmed.ncbi.nlm.nih.gov/41448435/). *J Biol Chem*. [Basic Science / Preclinical]
Sezer A (2026). [PMID: 41612845](https://pubmed.ncbi.nlm.nih.gov/41612845/). *J Pediatr Endocrinol Metab*. [Case Report / Case Series]
Zhuang J (2026). [PMID: 41620759](https://pubmed.ncbi.nlm.nih.gov/41620759/). *Hum Genomics*. [Basic Science / Preclinical]
Liu Y (2026). [PMID: 41719335](https://pubmed.ncbi.nlm.nih.gov/41719335/). *Proc Natl Acad Sci U S A*. [Basic Science / Preclinical]
Zemet R (2025). [PMID: 40423626](https://pubmed.ncbi.nlm.nih.gov/40423626/). *Prenat Diagn*. [Diagnostic / Biomarker]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 11:53 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Common questions about Meier-Gorlin syndrome 2
Bones and joints |
3 |
Delayed skeletal maturation, Joint hypermobility, Slender long bone |
Digestive system | 2 | Gastroesophageal reflux, Feeding difficulties |
Lungs and breathing | 1 | Bronchomalacia |
Head and neck | 1 | Microcephaly |
Age of onset: infancy.